엑소좀 기술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Exosome Technologies Market size is expected to reach USD 1763.30 Million in 2034 from USD 233.96 Million (2025) growing at a CAGR of 25.16% during 2026-2034.

The global exosome technologies market is experiencing rapid growth due to increasing research in cell-to-cell communication and advanced therapeutic applications. Exosomes play a crucial role in diagnostics, drug delivery, and regenerative medicine, making them highly valuable in biomedical research. The rising prevalence of chronic diseases and the growing demand for innovative treatment approaches are driving market expansion. Additionally, advancements in molecular biology and biotechnology are supporting the development of exosome-based technologies.

Key drivers include increasing investments in research and development and the growing focus on precision medicine. Exosome technologies offer potential advantages in targeted drug delivery and non-invasive diagnostics, which are attracting significant attention from the healthcare sector. Collaborations between academic institutions and biotechnology companies are accelerating innovation. Furthermore, improvements in isolation and characterization techniques are enhancing the efficiency and reliability of exosome-based applications.

In the future, the exosome technologies market is expected to witness substantial growth as research continues to uncover new applications. The development of standardized protocols and regulatory frameworks will support commercialization. Increasing adoption in clinical diagnostics and therapeutics will further drive market expansion. Emerging markets are anticipated to offer new opportunities due to rising healthcare investments and growing interest in advanced biomedical technologies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Exosome Type

• Loaded Cargos
• Non-cargo

By Cell Source

• HEK293 Cells
• MSCs
• Platelets
• Erythrocytes
• Natural Killer Cells
• Other

By Application

• Therapeutics
• Diagnostics

By End-user

• Health Care Providers
• Pharmaceutical & Biotechnology Companies
• Other

COMPANIES PROFILED

• Aegle Therapeutics, Aruna Bio Inc, BioTechne Corporation, Carmine Therapeutics Inc, Codiak BioSciences Inc, Creative Biolabs, Danaher Corporation Beckman Coulter Inc, Fujifilm Holdings Corporation, NOVADIP Biosciences SA, OmniSpirant Limited, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY EXOSOME TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Exosome Type
• 4.2. Loaded Cargos Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-cargo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY CELL SOURCE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Cell Source
• 5.2. HEK293 Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. MSCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Platelets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Erythrocytes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Natural Killer Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Health Care Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Exosome Type
  • 8.2.2 By Cell Source
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Exosome Type
  • 8.3.2 By Cell Source
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Exosome Type
  • 8.4.2 By Cell Source
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Exosome Type
  • 8.5.2 By Cell Source
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Exosome Type
  • 8.6.2 By Cell Source
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXOSOME TECHNOLOGIES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Aegle Therapeutics
  • 10.2.2 Aruna Bio Inc
  • 10.2.3 Bio-Techne Corporation
  • 10.2.4 Carmine Therapeutics Inc
  • 10.2.5 Codiak BioSciences Inc
  • 10.2.6 Creative Biolabs
  • 10.2.7 Danaher Corporation (Beckman Coulter Inc.)
  • 10.2.8 Fujifilm Holdings Corporation
  • 10.2.9 NOVADIP Biosciences S.A
  • 10.2.10 OmniSpirant Limited
  • 10.2.11 Thermo Fisher Scientific Inc